Literature DB >> 15381291

Identification of M1 and M2 muscarinic acetylcholine receptors in the cat carotid body chemosensory system.

M Shirahata1, S Hirasawa, M Okumura, J A Mendoza, A Okumura, A Balbir, R S Fitzgerald.   

Abstract

The carotid body is a major arterial chemoreceptor that senses low O2 tension, high CO2 tension and low pH in the arterial blood. It is generally believed that neurotransmitters, including acetylcholine (ACh), participate in the genesis of afferent neural output from the carotid body and modulate the function of chemoreceptor cells (glomus cells). Previous pharmacological studies suggest that M1 and M2 muscarinic ACh receptors (mAChRs) are involved in these processes. This study was designed to demonstrate the presence and localization of M1 and M2 mAChRs in the carotid body and in the petrosal ganglion of the cat. Since DNA sequences of the cat M1 and M2 mAChRs were not known, we first determined partial DNA sequences. These sequences and deduced amino acid sequences highly resembled those of human and the rat. Subsequent reverse transcription-polymerase chain reaction (RT-PCR)analysis has demonstrated that mRNAs for M1 and M2 mAChRs are present in the carotid body and the petrosal ganglion of the cat. Immunohistochemistry has indicated that the localization of these receptors appears different. Immunoreactivity for M1 mAChR was strong in nerves in the carotid body. Nerve endings positively stained for M1 mAChR appear to innervate glomus cells. Weak staining for M1 mAChRs was seen in glomus cells. On the other hand, M2 receptor protein seems to be present in glomus cells but not on nerve endings. One third of the neurons in the petrosal ganglion showed immunoreactivity for M1 mAChR. Many neurons and nerve fibers in the petrosal ganglion expressed M2 mAChR immunoreactivity. The results were consistent with previous pharmacological studies. Thus, activation of M1 mAChRs on afferent nerve endings may be linked to the increase in neural output during hypoxia. Further, M1 and M2 mAChRs on glomus cells modulate the release of neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381291     DOI: 10.1016/j.neuroscience.2004.06.068

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Distribution of voltage-gated potassium and hyperpolarization-activated channels in sensory afferent fibers in the rat carotid body.

Authors:  Maria Buniel; Patricia A Glazebrook; Angelina Ramirez-Navarro; Diana L Kunze
Journal:  J Comp Neurol       Date:  2008-10-01       Impact factor: 3.215

2.  The impact of adenosine and an A2A adenosine receptor agonist on the ACh-induced increase in intracellular calcium of the glomus cells of the cat carotid body.

Authors:  Robert S Fitzgerald; Machiko Shirahata; Irene Chang
Journal:  Brain Res       Date:  2009-09-15       Impact factor: 3.252

Review 3.  Carotid body chemoreceptors: physiology, pathology, and implications for health and disease.

Authors:  Rodrigo Iturriaga; Julio Alcayaga; Mark W Chapleau; Virend K Somers
Journal:  Physiol Rev       Date:  2021-02-11       Impact factor: 46.500

Review 4.  Revisiting cAMP signaling in the carotid body.

Authors:  Ana R Nunes; Andrew P Holmes; Sílvia V Conde; Estelle B Gauda; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

Review 5.  G-Protein-Coupled Receptor (GPCR) Signaling in the Carotid Body: Roles in Hypoxia and Cardiovascular and Respiratory Disease.

Authors:  Hayyaf S Aldossary; Abdulaziz A Alzahrani; Demitris Nathanael; Eyas A Alhuthail; Clare J Ray; Nikolaos Batis; Prem Kumar; Andrew M Coney; Andrew P Holmes
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

6.  Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis.

Authors:  Andrea Porzionato; Elena Stocco; Diego Guidolin; Luigi Agnati; Veronica Macchi; Raffaele De Caro
Journal:  Front Physiol       Date:  2018-06-07       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.